Cerebral palsy (CP) is caused by a static lesion to the brain occurring in utero or up to the
first 2 years of life; it often manifests as musculoskeletal impairments and movement …

Skeletal muscle contractures represent the permanent shortening of a muscle-tendon unit,
resulting in loss of elasticity and, in extreme cases, joint deformation. They may result from …

This review will provide a comprehensive, up-to-date review of the current knowledge
regarding the pathophysiology of muscle contractures in cerebral palsy. Although much has …

Background The analysis of in vitro cultures of human adult muscle stem cells obtained from
biopsies delineates the potential of skeletal muscles and may help to understand altered …

Background Measuring biological features of skeletal muscle cells is difficult because of
their unique morphology and multinucleate nature upon differentiation. Here, we developed …

Botulinum neurotoxin type-A (BoNT) injections are commonly used as spasticity treatment in
cerebral palsy (CP). Despite improved clinical outcomes, concerns regarding harmful effects …

Aim: Stretching is often used to increase/maintain muscle length and improve joint range of
motion (ROM) in children with cerebral palsy (CP). However, outcomes at the muscle …

Cerebral palsy (CP) is a heterogeneous group of motor disorders attributed to a non-
progressive lesion in the developing brain. Knowledge on skeletal muscle properties is …

Cerebral palsy is a set of common, severe, motor disabilities categorized by a static,
nondegenerative encephalopathy arising in the developing brain and associated with …

A myriad of musculoskeletal conditions afflicts a vast number of the world's population from
birth to death. Countless pathological diseases and traumatic injuries (acute and chronic) …